Abstract

Lyme borreliosis (LB), caused by bacteria of the Borrelia burgdorferi sensu lato (Borrelia) species, is the most common tick-borne infection in the northern hemisphere. LB diagnostics is based on clinical evaluation of the patient and on laboratory testing, where the main method is the detection of Borrelia specific antibodies in patient samples. There are, however, shortcomings in the current serology based LB diagnostics, especially its inability to differentiate ongoing infection from a previously treated one. Identification of specific biomarkers of diseases is a growing application of metabolomics. One of the main methods of metabolomics is nuclear magnetic resonance (NMR) spectroscopy. In the present study, our aim was to analyze whether Borrelia growth in vitro and infection in vivo in mice causes specific metabolite differences, and whether NMR can be used to detect them. For this purpose, we performed NMR analyses of in vitro culture medium samples, and of serum and urine samples of Borrelia infected and control mice. The results show, that there were significant differences in the concentrations of several amino acids, energy metabolites and aromatic compounds between Borrelia culture and control media, and between infected and control mouse serum and urine samples. For example, the concentration of L-phenylalanine increases in the Borrelia growth medium and in serum of infected mice, whereas the concentrations of allantoin and trigonelline decrease in the urine of infected mice. Therefore, we conclude that Borrelia infection causes measurable metabolome differences in vitro and in Borrelia infected mouse serum and urine samples, and that these can be detected with NMR.

Highlights

  • Lyme borreliosis (LB) is a multi-organ infectious disease caused by spirochetes of Borrelia burgdorferi sensu lato species

  • The mainstay of LB laboratory testing is the detection of Borrelia-specific antibodies in patient serum

  • We evaluated whether nuclear magnetic resonance spectroscopy (NMR) can be used to detect Borrelia-specific metabolites in vitro and in vivo in mice

Read more

Summary

Introduction

Lyme borreliosis (LB) is a multi-organ infectious disease caused by spirochetes of Borrelia burgdorferi sensu lato species (later Borrelia). In Finland, the annual incidence of disseminated LB is approximately 2,300 cases, and the number of local skin infections is three to five times that of the disseminated infections[2]. The mainstay of LB laboratory testing is the detection of Borrelia-specific antibodies in patient serum. This method performs well in the first episode of disseminated LB in a patient. Metabolomics is one approach in the field of the so-called omics sciences It uses cutting-edge analytical chemistry techniques combined with computational methods to characterize complex mixtures of molecules. Using metabolomics-based approaches, biomarker panels have been identified in a variety of human conditions: for example, in coronary heart disease, diabetes, nephropathy www.nature.com/scientificreports/. NMR has been shown to be an extremely useful tool in metabolomics, as different metabolites can be identified and quantified even from complex mixtures[18]

Objectives
Methods
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call